Spyridon Artavanis-Tsakonas

This inventor holds 24 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 3 EPO patents, primarily in Notch Pathway Research. Top assignees: Yale University, Imperial Cancer Research Technology, Ltd., Imperial Cancer Research Foundation, Ltd.. Active years: 1997-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Spyridon Artavanis-Tsakonas. Retrieved from https://idiyas.com/inventor/spyridon-artavanis-tsakonas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 1)

% Patents Active = 75.0

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.3

ph-index = 16

Forward Citations = 956(Granted Patents)

Location History:

Brookline, MA (US) (2011)
Hamden, CT (US) (1997 - 2013)

Company Filing History:

Imperial Cancer Research Technology, Ltd.

patents

1 out of 1

Imperial Cancer Research Foundation, Ltd.

6. 3 out of 834,601

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2013

Loading Chart...

Areas of Expertise:

Notch Proteins

Delta Proteins

Antibodies

Therapeutic Methods

Diagnostic Methods

Nucleotide Sequences

Protein Sequences

Serrate Proteins

Cell Manipulation

Modulators

Fragments

Binding Domains

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8415303 - Method of treatment using a soluble human delta protein fragment (2013-04-09),

2. 8222213 - Activated amino- and carboxy-terminal forms of Notch (2012-07-17),

3. 8084258 - Manipulation of tissue of organ type using the notch pathway (2011-12-27),

4. 7928071 - Nucleotide and protein sequences of vertebrate delta genes and methods based thereon (2011-04-19),

5. 7727732 - Methods for identifying modulators of Notch activation (2010-06-01),

6. 7118890 - Antibodies to vertebrate delta proteins and fragments (2006-10-10),

7. 6783956 - Nucleotide and protein sequences of vertebrate delta genes and methods based thereon (2004-08-31),

8. 6703489 - Antibodies to vertebrate serrate proteins and fragments (2004-03-09),

9. 6692919 - Activated forms of notch and methods based thereon (2004-02-17),

10. 6436650 - Activated forms of notch and methods based thereon (2002-08-20),

11. 6262025 - Nucleotide and protein sequences of vertebrate delta genes and methods based thereon (2001-07-17),

12. 6149902 - Manipulation of non-terminally differentiated cells using the notch (2000-11-21),

13. 6090922 - Antibodies to human notch proteins and fragments (2000-07-18),

14. 6083904 - Therapeutic and diagnostic methods and compositions based on notch (2000-07-04),

15. 6004924 - Protein sequences of serrate gene products (1999-12-21),

Title: The Innovative Journey of Spyridon Artavanis-Tsakonas

Introduction:

Spyridon Artavanis-Tsakonas is a renowned inventor hailing from Hamden, CT (US). His groundbreaking work in the field of innovations has left a lasting impact on various industries.

Latest Patents:

Spyridon Artavanis-Tsakonas holds several patents in his name, showcasing his continuous dedication to pushing the boundaries of technology and creativity.

Career Highlights:

Throughout his illustrious career, Spyridon Artavanis-Tsakonas has been instrumental in developing cutting-edge solutions that have revolutionized the way we interact with technology. His contributions have earned him a reputation as a visionary in the world of inventions.

Collaborations:

Spyridon Artavanis-Tsakonas has collaborated with leading companies, research institutions, and universities to bring his ideas to life. His ability to work seamlessly with others has led to the creation of innovative products that have changed the landscape of various industries.

Conclusion:

In conclusion, Spyridon Artavanis-Tsakonas stands as a beacon of innovation, inspiring others to think outside the box and pursue their creative visions. His remarkable journey as an inventor continues to shape the future of technology and beyond.

Profile summary based on public USPTO records.